Abstract
Aim:
This study was designed to capture patient preferences for different aspects of asthma treatment from people with asthma in the UK, the Netherlands and Spain.
Methods:
Asthma patients from the UK (n=124), the Netherlands (n=269) and Spain (n=86) participated in the survey. Patients' preferences and willingness to pay for a particular number of preventer inhalers, in relation to days per week with symptoms, days requiring reliever medication, risk of side effects, and requirement for a visit to their general practitioner (GP) or the Emergency Room (ER), were recorded.
Results:
Participants were willing to pay 荤35/month to avoid a day with symptoms, 荤109/month to avoid asthma attacks that required emergency visits to their GP or the ER, and 荤94/month to achieve total avoidance of asthma symptoms compared with their current state.
Conclusions:
This study presents European data regarding the importance to patients of different attributes of asthma and its treatment. Study participants placed high values on the avoidance of symptoms, and asthma attacks requiring medical attendance.
Keywords: asthma, patient preferences, willingness to pay, discrete choice experiment
Full Text
The Full Text of this article is available as a PDF (291.6 KB).
Footnotes
Andrew Lloyd worked for United BioSource Corp when this study was completed and UBC undertake consulting for the pharmaceutical Industry. Emma McIntosh has no conflicts of interest. Klaus F Rabe has no directly relevant conflicts of interest Angela Williams is an employee of GlaxoSmithKline R&D